Next Article in Journal
Acknowledgement to Reviewers of High-Throughput in 2017
Previous Article in Journal
Gradient Material Strategies for Hydrogel Optimization in Tissue Engineering Applications
 
 
Please note that, as of 21 September 2020, High-Throughput has been renamed to BioTech and is now published here.
Review

Could Proteomics Become a Future Useful Tool to Shed Light on the Mechanisms of Rare Neurodegenerative Disorders?

1
Department of Molecular Medicine, Biochemistry Unit, University of Pavia, 27100 Pavia, Italy
2
Department of Biology and Biotechnologies “L. Spallanzani”, Biochemistry Unit, University of Pavia, 27100 Pavia, Italy
*
Author to whom correspondence should be addressed.
High-Throughput 2018, 7(1), 2; https://doi.org/10.3390/ht7010002
Received: 20 November 2017 / Revised: 19 December 2017 / Accepted: 5 January 2018 / Published: 10 January 2018
Very often the clinical features of rare neurodegenerative disorders overlap with those of other, more common clinical disturbances. As a consequence, not only the true incidence of these disorders is underestimated, but many patients also experience a significant delay before a definitive diagnosis. Under this scenario, it appears clear that any accurate tool producing information about the pathological mechanisms of these disorders would offer a novel context for their precise identification by strongly enhancing the interpretation of symptoms. With the advent of proteomics, detection and identification of proteins in different organs/tissues, aimed at understanding whether they represent an attractive tool for monitoring alterations in these districts, has become an area of increasing interest. The aim of this report is to provide an overview of the most recent applications of proteomics as a new strategy for identifying biomarkers with a clinical utility for the investigation of rare neurodegenerative disorders. View Full-Text
Keywords: rare neurodegenerative disorders; proteomics; biomarkers; 2-DE; LC-MS/MS rare neurodegenerative disorders; proteomics; biomarkers; 2-DE; LC-MS/MS
Show Figures

Figure 1

MDPI and ACS Style

Cagnone, M.; Bardoni, A.; Iadarola, P.; Viglio, S. Could Proteomics Become a Future Useful Tool to Shed Light on the Mechanisms of Rare Neurodegenerative Disorders? High-Throughput 2018, 7, 2. https://doi.org/10.3390/ht7010002

AMA Style

Cagnone M, Bardoni A, Iadarola P, Viglio S. Could Proteomics Become a Future Useful Tool to Shed Light on the Mechanisms of Rare Neurodegenerative Disorders? High-Throughput. 2018; 7(1):2. https://doi.org/10.3390/ht7010002

Chicago/Turabian Style

Cagnone, Maddalena, Anna Bardoni, Paolo Iadarola, and Simona Viglio. 2018. "Could Proteomics Become a Future Useful Tool to Shed Light on the Mechanisms of Rare Neurodegenerative Disorders?" High-Throughput 7, no. 1: 2. https://doi.org/10.3390/ht7010002

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop